Page last updated: 2024-11-02

piribedil and Dementia

piribedil has been researched along with Dementia in 2 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oules, MJ1
Boscredon, J1
Scholing, WE1
Clausen, HD1

Trials

1 trial available for piribedil and Dementia

ArticleYear
[Psychological studies of a long-term treatment of the neurovascular syndrom with Trivastal (author's tranls)].
    Medizinische Klinik, 1975, Sep-19, Volume: 70, Issue:38

    Topics: Aged; Analysis of Variance; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical

1975

Other Studies

1 other study available for piribedil and Dementia

ArticleYear
[Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results].
    Annales medico-psychologiques, 1979, Volume: 137, Issue:9

    Topics: Adjustment Disorders; Aged; Dementia; Depression; Humans; Middle Aged; Piperazines; Piribedil

1979